There's never a dull week on Wall Street. Let's go over some of the news that will shape the week to come.

The market kicks off a new trading week with Ruckus Wireless (NYSE:RKUS) reporting quarterly results on Monday. The provider of wireless systems for the mobile Internet infrastructure market went public in November at $15. It moved lower initially, but the stock has crept into the high teens ahead of Monday's report.

ACADIA Pharmaceuticals (NASDAQ:ACAD) checks in on Tuesday. The biotech company's lead candidate is pimavanserin, a promising drug that's in the third and final phase of clinical development as a treatment for Parkinson's disease psychosis. Naturally, investors see red ink here, but analysts do see the quarterly deficit narrowing this time around.

Alon Partners USA (NYSE: ALDW) reports on Wednesday. Analysts see the oil refiner earning $1.36 per unit on Wednesday, and that's welcome news for investors. Alon Partners is set up as a limited partnership, passing on most of the money it makes to its stakeholders.

(NASDAQ:NVDA) steps up on Thursday. The graphics-chip pioneer has been gaining ground in tablets as smartphones as opportunities within the PC box are dimming.

Like many once high-flying tech darlings trying to woo income investors, NVIDIA began paying out quarterly dividends late last year. The stock commands a reasonable 2.2% yield for patient investors.

The market is typically quiet on Friday, but that's certainly not the case during earnings season. Abraxas Petroleum (NASDAQ:AXAS) checks in with its latest quarterly results on Friday morning. The San Antonio-based crude oil and natural gas exploration and production company is expected to post breakeven results.